Back to MREO
CITADEL ADVISORS LLC MREO Position History
Mereo BioPharma Group plc • Healthcare
Quarters held
53
Latest value
$14K
Q3 2026
Peak value
$4.8M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $707 |
| Q1 2023 | $2.2M |
| Q2 2023 | $528 |
| Q2 2023 | $2.3M |
| Q3 2023 | $6K |
| Q3 2023 | $2.9M |
| Q3 2023 | $5K |
| Q4 2023 | $22K |
| Q4 2023 | $36K |
| Q4 2023 | $240K |
| Q4 2023 | $510K |
| Q1 2024 | $109K |
| Q1 2024 | $239K |
| Q1 2024 | $1K |
| Q1 2024 | $144K |
| Q2 2024 | $100K |
| Q2 2024 | $361K |
| Q2 2024 | $1.3M |
| Q2 2024 | $221K |
| Q3 2024 | $69K |
| Q3 2024 | $467K |
| Q3 2024 | $142K |
| Q3 2024 | $394K |
| Q4 2024 | $294K |
| Q4 2024 | $341K |
| Q4 2024 | $229K |
| Q4 2024 | $870K |
| Q1 2025 | $172K |
| Q1 2025 | $78K |
| Q1 2025 | $773K |
| Q2 2025 | $1.8M |
| Q2 2025 | $169K |
| Q2 2025 | $310K |
| Q2 2025 | $270K |
| Q3 2025 | $1.8M |
| Q3 2025 | $53K |
| Q3 2025 | $4.8M |
| Q3 2025 | $114K |
| Q4 2025 | $55K |
| Q4 2025 | $257K |
| Q1 2026 | $128K |
| Q1 2026 | $22K |
| Q2 2026 | $4K |
| Q2 2026 | $160K |
| Q2 2026 | $137K |
| Q2 2026 | $16K |
| Q2 2026 | $4K |
| Q2 2026 | $160K |
| Q2 2026 | $137K |
| Q2 2026 | $16K |
| Q3 2026 | $119K |
| Q3 2026 | $17K |
| Q3 2026 | $14K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $14K | 35.1K | — | — |
| Q3 2026 | $17K | 42.6K | — | — |
| Q3 2026 | $119K | 296.3K | — | — |
| Q2 2026 | $16K | 51.0K | — | — |
| Q2 2026 | $137K | 430.8K | — | — |
| Q2 2026 | $160K | 504.9K | — | — |
| Q2 2026 | $4K | 13.4K | — | — |
| Q2 2026 | $16K | 51.0K | — | — |
| Q2 2026 | $137K | 430.8K | — | — |
| Q2 2026 | $160K | 504.9K | — | — |
| Q2 2026 | $4K | 13.4K | — | — |
| Q1 2026 | $22K | 67.8K | — | — |
| Q1 2026 | $128K | 387.0K | — | — |
| Q4 2025 | $257K | 617.2K | — | — |
| Q4 2025 | $55K | 131.5K | — | — |
| Q3 2025 | $114K | 55.3K | — | — |
| Q3 2025 | $4.8M | 2.32M | — | — |
| Q3 2025 | $53K | 25.7K | — | — |
| Q3 2025 | $1.8M | 853.6K | — | — |
| Q2 2025 | $270K | 99.8K | — | — |
| Q2 2025 | $310K | 114.4K | — | — |
| Q2 2025 | $169K | 62.2K | — | — |
| Q2 2025 | $1.8M | 646.3K | — | — |
| Q1 2025 | $773K | 343.7K | — | — |
| Q1 2025 | $78K | 34.7K | — | — |
| Q1 2025 | $172K | 76.5K | — | — |
| Q4 2024 | $870K | 248.6K | — | — |
| Q4 2024 | $229K | 65.3K | — | — |
| Q4 2024 | $341K | 97.3K | — | — |
| Q4 2024 | $294K | 83.9K | — | — |
| Q3 2024 | $394K | 95.7K | — | — |
| Q3 2024 | $142K | 34.5K | — | — |
| Q3 2024 | $467K | 113.6K | — | — |
| Q3 2024 | $69K | 16.7K | — | — |
| Q2 2024 | $221K | 61.5K | — | — |
| Q2 2024 | $1.3M | 347.5K | — | — |
| Q2 2024 | $361K | 100.3K | — | — |
| Q2 2024 | $100K | 27.9K | — | — |
| Q1 2024 | $144K | 43.6K | — | — |
| Q1 2024 | $1K | 304 | — | — |
| Q1 2024 | $239K | 72.5K | — | — |
| Q1 2024 | $109K | 33.0K | — | — |
| Q4 2023 | $510K | 220.9K | — | — |
| Q4 2023 | $240K | 103.9K | — | — |
| Q4 2023 | $36K | 15.4K | — | — |
| Q4 2023 | $22K | 9.7K | — | — |
| Q3 2023 | $5K | 3.8K | — | — |
| Q3 2023 | $2.9M | 2.24M | — | — |
| Q3 2023 | $6K | 5.0K | — | — |
| Q2 2023 | $2.3M | 1.77M | — | — |
| Q2 2023 | $528 | 400 | — | — |
| Q1 2023 | $2.2M | 3.05M | — | — |
| Q1 2023 | $707 | 1.0K | — | — |
Other funds holding MREO
$12.4M
$11.4M
$9.6M